Press Release / Aug 23, 2012
Hovione Announces the Appointment of Conrad Winters
Hovione Announces the Appointment of Conrad Winters, PhD as Drug Product Development Director
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione Announces the Appointment of Conrad Winters, PhD as Drug Product Development Director
Drug Development and Delivery, October 2012
The 12th successful inspection in 18 months
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Pharmaceutical Technology Sourcing and Management, July 2006